πŸ‡ΊπŸ‡Έ FDA
Patent

US 6838574

Dicarba-closo-dodecarborane derivatives

expired A61PA61P15/00A61P29/00

Quick answer

US patent 6838574 (Dicarba-closo-dodecarborane derivatives) held by Institute of Medicinal Molecular Design, Inc. expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Institute of Medicinal Molecular Design, Inc.
Grant date
Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P15/00, A61P29/00, A61P3/02, A61P3/10